
SABCS 2022 Conference Coverage
SABCS 2022 Dose-Expansion Study DESTINY-Breast07: T-DXd as Monotherapy or Combined With Pertuzumab in Patients With Metastatic HER2+ BC
By
SABCS 2022 Conference Coverage
FEATURING
Erika Hamilton
By
SABCS 2022 Conference Coverage
FEATURING
Erika Hamilton
179 views
December 22, 2022
Comments 0
Login to view comments.
Click here to Login
Videos